Kamar Aulakh joins Velos
This article was originally published in Scrip
Executive Summary
Velos (US), a clinical trial management resource for investigators, sponsors and academic leaders, has named Kamar Aulakh chief operating officer. He was previously president and CEO of Quark, a developer of software solutions for publishers. He has also held positions in Fortune 500 companies working in the telecommunications, energy and healthcare sectors.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.